146 related articles for article (PubMed ID: 2076859)
1. Central activation of thermogenesis by prostaglandins: dependence on CRF.
Rothwell NJ
Horm Metab Res; 1990 Dec; 22(12):616-8. PubMed ID: 2076859
[TBL] [Abstract][Full Text] [Related]
2. CRF is involved in the pyrogenic and thermogenic effects of interleukin 1 beta in the rat.
Rothwell NJ
Am J Physiol; 1989 Jan; 256(1 Pt 1):E111-5. PubMed ID: 2783532
[TBL] [Abstract][Full Text] [Related]
3. Thermogenic actions of tryptophan in the rat are mediated independently of 5-HT.
Serra F; LeFeuvre RA; Slater D; Palou A; Rothwell NJ
Brain Res; 1992 Apr; 578(1-2):327-34. PubMed ID: 1511284
[TBL] [Abstract][Full Text] [Related]
4. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
Lu L; Liu D; Ceng X; Ma L
Eur J Neurosci; 2000 Dec; 12(12):4398-404. PubMed ID: 11122350
[TBL] [Abstract][Full Text] [Related]
5. An interleukin-1 beta-induced noradrenaline release in the spleen is mediated by brain corticotropin-releasing factor: an in vivo microdialysis study in conscious rats.
Shimizu N; Hori T; Nakane H
Brain Behav Immun; 1994 Mar; 8(1):14-23. PubMed ID: 8003768
[TBL] [Abstract][Full Text] [Related]
6. Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function.
MartÃnez V; Rivier J; Wang L; Taché Y
J Pharmacol Exp Ther; 1997 Feb; 280(2):754-60. PubMed ID: 9023288
[TBL] [Abstract][Full Text] [Related]
7. Reduction of exploratory behavior by intraperitoneal injection of interleukin-1 involves brain corticotropin-releasing factor.
Dunn AJ; Antoon M; Chapman Y
Brain Res Bull; 1991 Apr; 26(4):539-42. PubMed ID: 1868353
[TBL] [Abstract][Full Text] [Related]
8. Acute stress modulates the histamine content of mast cells in the gastrointestinal tract through interleukin-1 and corticotropin-releasing factor release in rats.
Eutamene H; Theodorou V; Fioramonti J; Bueno L
J Physiol; 2003 Dec; 553(Pt 3):959-66. PubMed ID: 14555722
[TBL] [Abstract][Full Text] [Related]
9. Differential antagonist activity of alpha-helical corticotropin-releasing factor9-41 in three bioassay systems.
Fisher L; Rivier C; Rivier J; Brown M
Endocrinology; 1991 Sep; 129(3):1312-6. PubMed ID: 1651845
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of LH release by CRF may be partially mediated through hypothalamic beta-endorphin release.
Nikolarakis KE; Almeida OF; Herz A
NIDA Res Monogr; 1986; 75():403-5. PubMed ID: 2963219
[TBL] [Abstract][Full Text] [Related]
11. Central effects of TNF alpha on thermogenesis and fever in the rat.
Rothwell NJ
Biosci Rep; 1988 Aug; 8(4):345-52. PubMed ID: 3263887
[TBL] [Abstract][Full Text] [Related]
12. Behavioral effects of central administration of the novel CRF antagonist astressin in rats.
Spina MG; Basso AM; Zorrilla EP; Heyser CJ; Rivier J; Vale W; Merlo-Pich E; Koob GF
Neuropsychopharmacology; 2000 Mar; 22(3):230-9. PubMed ID: 10693150
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of central actions of cytokines on fever and thermogenesis by lipocortin-1 involves CRF.
Strijbos PJ; Hardwick AJ; Relton JK; Carey F; Rothwell NJ
Am J Physiol; 1992 Oct; 263(4 Pt 1):E632-6. PubMed ID: 1415682
[TBL] [Abstract][Full Text] [Related]
14. Effect of a central CRF antagonist on cardiovascular and thermoregulatory responses induced by stress or IL-1 beta.
Nakamori T; Morimoto A; Murakami N
Am J Physiol; 1993 Oct; 265(4 Pt 2):R834-9. PubMed ID: 8238454
[TBL] [Abstract][Full Text] [Related]
15. Thyrotropin-releasing factor-induced adrenocorticotropin secretion is mediated by corticotropin-releasing factor.
Brown MR; Carver-Moore K; Gray TS; Rivier C
Endocrinology; 1989 Nov; 125(5):2558-62. PubMed ID: 2551657
[TBL] [Abstract][Full Text] [Related]
16. Treatment with alpha-helical-CRF(9-41) prevents the anorectic effect of 17-beta-estradiol.
Dagnault A; Ouerghi D; Richard D
Brain Res Bull; 1993; 32(6):689-92. PubMed ID: 8221168
[TBL] [Abstract][Full Text] [Related]
17. Effects of alpha helical CRF 9-41 on neurophysiological and autonomic patterns induced by CRF in the rabbit.
Marchioni E; Maurelli M; Tartara A
Boll Soc Ital Biol Sper; 1993 Apr; 69(4):265-72. PubMed ID: 8129907
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9-41).
Swerdlow NR; Britton KT; Koob GF
Neuropsychopharmacology; 1989 Dec; 2(4):285-92. PubMed ID: 2610824
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological comparison of two corticotropin-releasing factor antagonists: in vivo and in vitro studies.
Curtis AL; Grigoriadis DE; Page ME; Rivier J; Valentino RJ
J Pharmacol Exp Ther; 1994 Jan; 268(1):359-65. PubMed ID: 8301577
[TBL] [Abstract][Full Text] [Related]
20. Differential dose effects of central CRF and effects of CRF astressin on pig behavior.
Salak-Johnson JL; Anderson DL; McGlone JJ
Physiol Behav; 2004 Oct; 83(1):143-50. PubMed ID: 15501501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
